TSP-1 serum levels were significantly lower in the patients with lung cancer than in the controls (TSP-1: 10,109.2 ± 9581 ng/mL vs. 11,415.09 ± 9781 ng/mL p = 0.012), Figure 1. This evidence concerns the gene THBS1 and lung cancer.